Brain (and spinal cord) tumours
Results
Other
This trial looked at a drug called 5-aminolevulinic acid (5-ALA) to see if it could help surgeons confirm the of a brain tumour during surgery. 5-ALA is also called Gliolan.
This trial was for people with a type of brain tumour called a glioma.
It was supported by Cancer Research UK. People could join the trial between 2015 and 2017. The team published the results in 2023.
Recruitment start: 28 February 2015
Recruitment end: 8 March 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Colin Watts
Cambridge University Hospitals NHS Foundation Trust
Cancer Research UK
NIHR Clinical Research Network: Cancer
University of Cambridge
NIHR Cambridge Biomedical Research Centre
Last reviewed: 09 Jun 2026
CRUK internal database number: 12588